2019年3月27日星期三

4-fluorophenyl

Product name: (-)-Trans-1-methyl-3-hydroxymethyl-4-(4-fluorophenyl)piperdine
CAS no.: 105812-81-5
Molecular Formula: C13H18FNO
Molecular Weight: 223.29
Appearance: White or white crystalline solids
Product description: Paroxetine intermediate.

Tozasertib

Product name:Tozasertib
CAS: 639089-54-6
Molecular Formula: C23H28N8OS
Molecular weight:464.59
Appearance:white powder
Purity:99%
Product description :Tozasertib inhibits Aurora kinases A, B and C with Ki values of 0.6, 18 and 4.6 nM, respectively. It also inhibits Flt-3 and Abl as well as their mutant forms.

Trans-1,4-diaminocyclohexane

Product name:Trans-1,4-diaminocyclohexane
CAS no.:2615-25-0
Molecular formula:C6H14N2
Molecular weight:114.1888
Appearance:Pale white amorphous crystal
Purity:99.0%
Product description:Enterprise standard.

Torasemide

Product name: Torasemide
CAS no.: 56211-40-6
Molecular Formula: C16H20N4O3S
Molecular Weight: 348.42
Product description: Used as a diuretic.

Toremifene

Product name:Toremifene
CAS: 114977-28-5
Molecular Formula:C26H28CINO.C6H8O7
Molecular Weight: 598.09
Product description:This product is a white to pale yellow powder.It is suitable for the treatment of women before and after menopause females, progesterone receptor, and/or metastatic breast cancer is unknown.

Trankimazin

Product name:Trankimazin
CAS: 28981-97-7
Molecular Formula: C17H13ClN4
Molecular Weight: 308.77
Product description:Is mainly used for anxiety, tension, exciting, can also be used for adjuvant hypnosis or anxiety, as a panic drug resistance, and can ease the acute alcohol withdrawal symptoms and so on.

Tranilast

Product name: Tranilast
CAS: 53902-12-8
Molecular Formula: C18H17NO5
Molecular Weight: 327.34
Product description:Light yellow or yellowish green crystal or white crystalline powder, odourless, tasteless. Soluble in N, N - dimethyl formamide, soluble in pyridine, dioxane, slightly soluble in methanol, ethanol, acetone, chloroform, insoluble in water, benzene, cyclohexane.Has a stable of mast cells and basophilic granulocyte cell membrane, prevent the degranulation. Thus inhibition of histamine and serotonin allergic reaction material release, the IgE antibody caused rat skin allergic reactions and has significant inhibitory effect on experimental asthma, is a mechanism for allergic disease etiology of therapeutic drugs.